Flow cytometric analysis of apoptosis and BCL-2 in primary breast carcinomas: Clinical and biological implications

Cytometry

Volumn 24, Issue 2, 1996, Pages 116-122

  Steck, Kim ^a   McDonnell, Timothy ^a   Sneige, Nour ^a   El Naggar, Adel ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Apoptosis; bcl 2; Flow cytometry; Mammary carcinoma

Indexed keywords

PROTEIN BCL 2;

APOPTOSIS; ARTICLE; BREAST CARCINOMA; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL DIVISION; CELL LINE; DNA DAMAGE; FEMALE; FLOW CYTOMETRY; HUMANS; MIDDLE AGED; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0029955620     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(19960601)24:2<116::AID-CYTO3>3.0.CO;2-H     Document Type: Article

References (53)

1. Aiello A, Delia D, Borrello MG, Biassoni O, Giardini R, Fontanella E, Pezzella F, Pulford K, Pierotti M, Della Porta G: Flow cytometric detection of the mitochondrial bcl-2 protein in normal and neoplastic human lymphoid cells. Cytometry 13:502-509, 1992.
2. Askew DS, Ashmun RA, Simmons BC, Cleveland JL: Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 6:1915-1922, 1991.
3. Bhargava V, Kell DL, van de Rijn M, Warnke RA: Bcl-2 imimmoreactivity in breast carcinoma correlates with hormone receptor positivity. Am J Pathol 145:535-540, 1994.
4. Black MM, Speer FD: Nuclear structure in cancer tissues. Am J Clin Pathol 26:250-256, 1956.
5. Campos L, Rouault J-P, Sabido O, Oriol P, Roubi N, Vasselon C, Archimbaud E, Magaud J-P, Guyotat D: High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood 81:3091-3096, 1993.
6. a, 1993.
7. Chandler D, EI-Naggar AK, Brisbay S, Redline RW, McDonnell TJ: Apoptosis and expression of the bcl-2 proto-oncogene in the fetal and adult human kidney. Hum Pathol 25:789-796, 1994.
8. Delia D, Aiello A, Soligo D, Fontanella E, Melani C, Pezzella F, Pierotti MA, Della Porta G: bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells. Blood 79:1291-1298, 1992.
9. Doglioni C, Dei Tos AP, Laurino L, Chiarelli C, Barbareschi M, Viale G: The prevalence of bcl-2 immunoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to oestrogen receptor status. Virchows Archiv 424:47-51, 1994.
10. Fisher DE: Apoptosis in cancer therapy: Crossing the threshold. Cell 78:539-542, 1994.
11. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493-501, 1992.
12. Gee JMW, Robertson JFR, Ellis IO, Willsher P, McClelland RA, Hoyle HB, Kyme SH, Finaly P, Blarney RW, Nicholson RI: Immunocytochemical localization of bcl-2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy. Int J Cancer 59:619-628, 1994.
13. Gorczyca W, Gong J, Darzynkiewicz Z: Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res 53:1945-1951, 1993.
14. Gorczyca W, Tuziak T, Kram A, Melamed MR, Darzynkiewicz Z: Detection of apoptosis-associated DNA strand breaks in fine-needle aspiration biopsies by in situ end labeling of fragmented DNA. Cytometry 15:169-175, 1994.
15. Hellemans P, van Dam PA, Weyler J, van Oosterom AT, Buytaert P, Van Marck E: Prognostic value of bcl-2 expression in invasive breast cancer. Br J Cancer 72:354-360, 1995.
16. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334-336, 1990.
17. Hockenbery DM, Zutter M, Hickey W, Nahm M, Korsmeyer SJ: Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci 88:6961-6965, 1991.
18. Hockenbery DM. Bcl-2, a novel regulator of cell death. BioEssays 17:631-638, 1995.
19. Ikegaki N, Katsumata M, Minna J, Tsujimoto Y: Expression of bcl-2 in small cell lung carcinoma cells. Cancer Res 54:6-8, 1994.
20. Joensuu H, Pylkkanen L, Toikkanen S: Bcl-2 protein expression and long-term survival in breast cancer. Am J Pathol 145:1191-1198, 1994.
21. Johnston SRD, MacLennan KA, Sacks NPM, Salter J, Smith IE, Dowsett M: Modulation of bcl-2 and Ki-67 expression in oestrogen receptor-positive human breast cancer by tamoxifen. European J Cancer 30A:1663-1669, 1994.
22. Kasagi N, Gomyo Y, Shirai H, Tsujitani S, Ito H: Apoptotic cell death in human gastric carcinoma: Analysis by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling. Jpn J Cancer Res 85:939-945, 1994.
23. Kondo E, Nakamura S, Onoue H, Matsuo Y, Yoshino T, Aoki H, Hayashi K, Takahashi K, Minowada J, Nomura S, Akagi T: Detection of bcl-2 protein and bcl-2 messenger RNA in normal and neoplastic lymphoid tissues by immunohistochemistry and in situ hybridization. Blood 80:2044-2051, 1992.
24. Korsmeyer SJ: Bcl-2 initiates a new category of oncogenes: Regulators of cell death. Blood 80:879-886, 1992
25. Krajewski S, Tanaka S, Takayama S, Schibler MJ, Fenton W, Reed JC: Investigations of the subcellular distribution of the bcl-2 oncoprotein: Residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res 53:4701-4714, 1993.
26. 2+ fluxes. Proc Natl Acad Sci 91:6569-6573, 1994.
27. Leek RD, Kaklamanis L, Pezzella F, Gatter KC, Harris AL: Bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumors and in situ cancer. Br J Cancer 69:135-139, 1994.
28. Lipponen P, Aaltomaa S, Kosma V-M, Syrjänen K: Apoptosis in breast cancer as related to histopathological characteristics and prognosis. Eur J Cancer 30A:2068-2073, 1994.
29. Lipponen P, Aaltomaa S: Apoptosis in bladder cancer as related to standard prognostic factors and prognosis. J Pathol 173:333-339, 1994.
30. Lipponen P, Pietiläinen T, Kosma V-M, Aaltomaa S, Eskelinen M, Syrjänen K: Apoptosis suppressing protein bcl-2 is expressed in well-differentiated breast carcinomas with favourable prognosis. J Pathol 177:49-55, 1995.
31. Lu Q-L, Elia G, Lucas S, Thomas JA: Bcl-2 proto-oncogene expression in Epstein-Barr-virus associated nasopharyngeal carcinoma. Int J Cancer 53:29-35, 1993.
32. Lu Q-L, Poulsom R, Wong L et al: Bcl-2 expression in adult and embryonic non-haematopoietic tissues. J Pathol 169:431-437, 1993.
33. Maung ZT, MacLean FR, Reid MM, Pearson ADJ, Proctor SJ, Hamilton PJ, Hall AG: The relationship between bcl-2 expression and response to chemotherapy in acute leukaemia. Br J Haematology 88:105-109, 1994.
34. McDonnell TJ, Deane N, Platt FM, Nunez G, Jaeger U, McKearn JP, Korsmeyer SJ: Bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 57:79-88, 1989.
35. McDonnell TJ, Troncoso P, Brisbay SM, Logothetis C, Chung LWK, Hsieh J-T, Tu S-M, Campbell ML: Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res 52:6940-6944, 1992.
36. Miyashita T, Reed JC: Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 81:151-157, 1993.
37. Miyazaki T, Liu Z-J, Kawahara A, Minami Y, Yamada K, Tsujimoto Y, Barsoumian EL, Perlmutter RM, Taniguchi T: Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and Ick cooperate in hematopoietic cell proliferation. Cell 81:223-231, 1995.
38. Monaghan P, Roberston D, Amos AS, Dyer MJS, Mason DY, Greaves MF: Ultrastructural localization of bcl-2 protein. J Histochem Cytochem 40:1819-1825, 1992.
39. Nathan B, Gusterson B, Jadayel D, O'Hare M, Anbazhagan R, Jayatilake H, Ebbs S, Micklem K, Price K, Gelber R, Reed R, Senn H-J, Goldhirsch A, Dyer MJS: Expression of bcl-2 in primary breast cancer and its correlation with tumour phenotype. Annals Oncology 5:409-414, 1994.
40. Naumovski I, Cleary ML: Bcl2 inhibits apoptosis associated with terminal differentiation of HL-60 myeloid leukemia cells. Blood 83:2261-2267, 1994.
41. Overton WR: Modified histogram subtraction technique for analysis of flow cytometry data. Cytometry 9:619-626, 1988.
42. Pezzela F, Turley H, Kuzu I, Tungekar MF, Dunnill MS, Pierce CB, Huris A, Gatter KG, Mason DY: bcl-2 protein in non-small-cell lung carcinoma. N Engl J Med 329:690-694, 1993.
43. Rasbridge SA, Gillett CE, Seymour A-M, Patel K, Richards MA, Rubens RD, Millis RR: The effects of chemotherapy on morphology, cellular proliferation, apoptosis and oncoprotein expression in primary breast carcinoma. Br J Cancer 70:335-341, 1994.
44. Rodriquez-Villanueva J, Colome MI, Brisbay S, McDonnell TJ: The expression and localization of bcl-2 protein in normal skin and in non-melanoma skin cancers. Path Res Pract 191:391-398, 1995.
45. Saegusa M, Takano Y, Okayasu I: Bcl-2 expression and its association with cell kinetics in human gastric carcinomas and intestinal metaplasia. J Cancer Res & Clin Oncol 121:357-363, 1995.
46. Schena M, Larsson L-G, Gottardi D, Gaidano G, Carlsson M, Nilsson K, Caligaris-Cappio F: Growth- and differentiation-associated expression of bcl-2 in B-chronic lymphocytic leukemia cells. Blood 79:2981-2989, 1992.
47. Sierra A, Lloveras B, Castellsague X, Moreno L, Garcia-Ramirez M, Fabra A: Bcl-2 expression is associated with lymph node metastasis in human ductal breast carcinoma. Int J Cancer 60:54-60, 1995.
48. Silvestrini R, Vencroni S, Daidone MG, Benini E, Boracchi P, Mezzetti M, Di Fronzo G, Rilke F, Veronesi U: The bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients. J Natl Cancer Inst 86:499-504, 1994.
49. Steck KD, McDonnell TJ, El-Naggar AK: Flow cytometric analysis of apoptosis and bcl-2 in human solid neoplasms. Cytometry 20:154-161, 1995.
50. Teixeira C, Reed JC, Pratt MAC: Estrogen promotes chemotherapeutic drug resistance by a mechanism involving bcl-2 proto-oncogene expression in human breast cancer cells. Cancer Res 55:3902-3907, 1995.
51. Vaux DL, Cory S, Adams JM: Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335:440-442, 1988.
52. Wang TTY, Phang JM: Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7. Cancer Res 55:2487-2489, 1995.
53. Wyllie AH: Apoptosis (The 1992 Frank Rose Memorial Lecture). Br J Cancer 67:205-208, 1993.